Literature DB >> 12787662

Intoxication due to 1,4-butanediol.

C Lora-Tamayo1, T Tena, A Rodríguez, J R Sancho, E Molina.   

Abstract

We report a case of intoxication resulting from the ingestion of a liquid, sold in the illicit market as "liquid ecstasy," which was found to contain 1,4-butanediol, a metabolic precursor of gamma-hydroxybutiric acid (GHB). Identification of the substance in the liquid was performed by gas chromatography-mass spectrometry (GC-MS). The toxicological analysis of blood, urine and gastric content of the victim was performed by immunoassay and gas chromatography with nitrogen-phosphorus detection as screening techniques and by means of GC-MS for confirmation and quantitation of 1,4-butanediol and GHB. The following drug concentrations were found: 82 microg/ml (blood), 401 microg/ml (urine) and 7.4 microg/ml (gastric content) for 1,4-butanediol and 103 microg/ml (blood), 430.0 microg/ml (urine) for GHB. In addition to these, other drugs detected and their blood concentration found in this case were methylenedioxymethylamphetamine (MDMA) 0.23 microg/ml and its metabolite methylenedioxyphenylamphetamine (MDA) 0.10 microg/ml. In the urine, a concentration of 0.10 microg/ml of benzoylecgonine was also found.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787662     DOI: 10.1016/s0379-0738(02)00424-3

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  2 in total

1.  Inhibition of 1,4-butanediol metabolism in human liver in vitro.

Authors:  Daniel Lenz; Martin Jübner; Katja Bender; Annette Wintermeyer; Justus Beike; Markus A Rothschild; Herbert Käferstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-02       Impact factor: 3.000

2.  Butanediol Conversion to Gamma-Hydroxybutyrate Markedly Reduced by the Alcohol Dehydrogenase Blocker Fomepizole.

Authors:  Evangelia Liakoni; Hallam Gugelmann; Delia A Dempsey; Timothy J Wiegand; Christopher Havel; Peyton Jacob; Neal L Benowitz
Journal:  Clin Pharmacol Ther       Date:  2019-01-08       Impact factor: 6.875

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.